The emergence of positive data on the use of sodium glucose co-transporter inhibitors (SGLT2i) in the last several years, begged the question of whether their

Serum uric acid may predict the onset and progression of kidney disease, and the occur- rence of cardiovascular (CVM) and allcause mortality (ACM). Nevertheless, it

Factors other than the HLA – match might have an impact on transplant outcomes. New studies showed that genomic factors can increase the risk of

Following renal transplantation, patients are at risk of developing a wide range of complications. These may include hematological disorders, including relatively benign anemia through cytopenias

Many patients develop chronic kidney disease (CKD) after acute kidney injury (AKI). The risk of CKD increases more than eight-fold after AKI. In his presentation,

Many patients with the rare kidney disease FSGS require dialysis in the course of the d i s e a s e , d e

Due to the immunological pathogenesis of IgA nephropathy (IgAN), patients used to be given immunosuppressive therapy; however, this was shown to have no long-term benefit

C3 glomerulopathy is a rare disease in which the deposition of C3 protein causes severe inflammation of the glomeruli, which can progress to end stage

Neprilysin inhibition (NEPi) combined with a reninangiotensin system (RAS) blocker has been shown to play an important role among patients with heart failure (HF), whose

Hyponatremia is associated with aggravation of inflammation in COVID-19 patients. However, to the best of our knowledge, no study has used longitudinal data and investigated